The present invention relates to a closing cap for a container which is filled with a medical liquid, in particular for infusion or transfusion, in particular a bottle-shaped container filled with a liquid for parenteral feeding. Moreover, the invention relates to a container for a medical liquid for infusion or transfusion, in particular a bottle-shaped container to be filled with a liquid for parenteral feeding, which has one such closing cap.
Various containers for medical liquids are known. The containers include on the one hand the known bags comprising multi-layered films, which are distinguished by transparency, flexibility and sealability, and on the other hand the known bottles, which have different shapes. The bags and bottles differ in the design of the accesses for the removal and supply of the medical liquids, which are also referred to as ports.
German patent document DE 102 23 560 A1 describes a bag with a port system, which comprises a removal and injection site. The port system has two separate connectors, one of which is used for the removal of the liquid and the other for the injection of an additive. For the removal of the liquid, use is generally made of a so-called spike, which has a relatively large diameter, whilst for the injection of the additive a cannula is used, which has a relatively small diameter. In this regard, different demands are made on the design of the removal and the injection site.
The known bottles, which represent an alternative to the frequently used bags, are obturated with a cap. Such closing caps are also known as so-called Euro caps, which are standardized in DIN 58374.
There is known from International Publication Number WO 02/098748 A1 a closing cap for a medicine bottle, which closing cap has a removal and injection site. A common membrane made from an elastic material is used to seal the removal and injection site, said membrane being piercable with a piercing part (spike) of an infusion device for removing the medicine and a cannula of a syringe for injecting an additive. The membrane, which is also referred to as a septum, is welded fast to the cap.
A closure for a medicine bottle is also known from European patent document EP 0 364 783 B1. This closure is also characterized by a common septum for the port for removing the medicine and injecting the additive.
The membranes used in medical technology must meet high demands. The membranes should, on the one hand, be able to be pierced with little effort and, on the other hand, the container should be sealed securely. After the puncturing and the removal of the cannula, the membrane for sealing the injection site should be tight. The membrane of the removal site should additionally hold fast the piercing part in the presence of tensile load, so that the piercing part cannot slide out of the piercing site.
A medicine container with a pot-shaped cap, into which two membranes are inserted, is known from European patent document EP 1 010 635 B1. The two membranes are however configured identically.
An objective of the present invention is to make available a closing cap for containers with a removal and injection site which are filled with medical liquids, in particular liquids for infusion or transfusion, said closing cap permitting reliable handling when removing the medical liquid and injecting the additive.
A further objective of the present invention is to provide a container for a medical liquid, in particular a liquid for infusion or transfusion, with such a closing cap.
According to the closing cap of the present invention, the removal and injection sites are configured as separate accesses with different openings, which are each obturated by a pierceable self-sealing membrane. The closing cap does not therefore have a common membrane for both accesses, but two membranes which are configured differently. In this connection, a different configuration is understood to mean, for example, different shapes or materials.
The decisive advantage of the closing cap, according to the invention, lies in the fact that the use of separate membranes for the removal and injection sites permits optimum adaptation to the different requirements that are made on these accesses. Since the port system has membranes of differing configuration, the removal and injection sites can be adapted in the optimum manner to the specific requirements during the removal of a liquid by means of a piercing part (spike), which has a relatively large diameter, and during the injection of an additive by means of a cannula, which has a relatively small diameter.
The membrane of the removal site can be configured in such a way that the port can be pierced with a piercing part (spike), the spike being held fast in the presence of tensile load and the removal site being securely sealed, whilst the membrane of the injection site can be designed in such a way that the port is tight after puncturing and removal of the cannula.
According to a preferred embodiment of the closing cap, both membranes are held in a clamped manner in the cap. The membranes can also be elastically deformed. The assembly of the closing cap can therefore take place in a straightforward manner solely by pressing of the individual parts. It is however also possible for the membranes to be welded and/or glued to the cap.
Another preferred embodiment makes provision such that the openings for the membranes are recesses in the lid part of the cap, in which the membranes are inserted in a matching fashion. The form-fit connection guarantees that the membranes have a secure hold.
According to a particularly preferred embodiment, a retaining plate, with which the membranes are clamped, is arranged at the inside of the lid part of the cap. For this purpose, the retaining plate preferably has shoulders engaging beneath the membranes.
Another alternative embodiment provides for shoulders engaging beneath the membranes, which shoulders are provided not on the retaining plate, but at the inside of the lid part. The shoulders are preferably in one piece with the lid part. The assembly can be further simplified if the shoulders are flexible parts. The membranes then merely have to be inserted into the lid part and the shoulders turned up. The shoulders are preferably configured as annular flanges, which offer a secure hold.
According to a further particularly preferred embodiment, the retaining plate is inserted into the closing cap in a lock-in or snap-in manner. For the fitting, the membranes are inserted into the lid part and then the retaining plate into the side part of the cap.
The retaining plate can however also be in one piece with the side part, the lid part being configured as a cap body which can be folded down from the side part. The membranes are then inserted into the folded-down cap body and the cap body is then folded onto the retaining plate, so that the membranes are clamped between the cap body and the retaining plate.
The cap body is preferably fixed with a hinge to the side part. Such hinges are known as so-called film hinges in plastics technology.
The first and/or second openings in the cap are preferably obturated with a twist-off part, which forms as it were an originality seal. The handling is preferably improved by the fact that the twist-off parts are configured as flat grip parts. The twist-off parts expediently each have a marking, in particular a recess configured in the manner of an arrow. Since the arrows point in opposite directions to one another, it can immediately be recognized that the given port is a removal site or an injection site.
The self-sealing membrane of the removal site preferably has an outer annular portion, which is followed by a middle annular portion with an upper and lower seating face, said middle annular portion being held in a clamped manner in the cap. The middle annular portion transforms into an inner plate-shaped portion, at the upper side of which a trough-shaped recess is formed. The inner plate-shaped portion preferably has a flat underside. The special configuration of the membrane ensures on the one hand that the spike is guided and held securely when piercing the membrane and on the other hand guarantees that, after withdrawal of the spike, the membrane reliably seals again even in the presence of relatively high internal pressure in the container. It has been shown in tests that the special configuration of the membrane is decisive for the immediate re-sealing, the sealing of the membrane being increased further with increasing internal pressure in the packaging.
The membrane of the removal site is preferably weakened, so that it can easily be pierced with a spike. The membrane is preferably pre-slit in the form of a cross. It can however also be slit in the shape of a star or be provided only with a single slit.
The membrane of the injection site differs from the membrane of the removal site by its cross-section in the centre. The membrane of the injection site preferably has a larger cross-section than the membrane of the removal site, i.e. one membrane is thicker in the centre than the other membrane.
The membrane of the injection site also preferably has an outer annular portion. The outer annular portion, however, is directly followed by the inner plate-shaped portion, trough-shaped recesses being formed both at the upper side and the lower side of the inner plate-shaped portion. A high degree of tightness is achieved with the special geometry of the membrane.
The, in particular, bottle-shaped container according to the invention for medical liquids can have different shapes. Apart from round shapes, oval or flattened shapes are also possible.
a shows a further example of embodiment of the cap according to the invention before the fixing of the membranes in the lid part.
b shows the cap from
In the following exemplary embodiments a device in accordance with the present invention is explained in greater detail by reference to the figures.
Closing cap 1 has a round lid part 2, which is followed by a cylindrical side part 3. Located at the lower edge of side part 3 is a flange 4 for fixing the cap to the head of a bottle. Lid part 2 has a larger wall thickness than side part 3.
Cap 1 has a port system 5 with a removal site 6 and an injection site 7. The port system is described in detail below.
Lid part 2 of cap 1 has two openings 8, 9 with a preferably circular cross-section, said openings being arranged at a distance from one another. A first self-sealing membrane 10 for removal site 6 sits in first opening 8 and a second self-sealing membrane 11 for the injection site in second opening 9. The two membranes are configured differently. They are made from an elastic material, preferably from a synthetic rubber, preferably from polyisoprene.
First membrane 10 for removal site 6 has an outer annular portion 10a, which is followed by a middle annular portion 10b, which has a smaller diameter than the outer portion. Middle annular portion 10b, which has an upper and lower seating face, is held in a clamped manner in the cap. Middle annular portion 10b transforms into an inner plate-shaped portion 10c, at the upper side of which an upper mould-shaped recess 10d is formed. Plate-shaped portion 10c has a flat underside 10e. The plate-shaped portion is pre-slit in the form of a cross or star in the centre of trough-shaped recess 10d, in such a way that the elastic material is weakened, but not severed.
Second membrane 11 for injection site 7, which is thicker than first membrane 10, has an outer annular portion 11a with an upper and lower seating face, said outer annular portion being held in a clamped manner in the cap. Annular portion 11a is followed directly by an inner plate-shaped portion 11b, at the upper and lower side of which an upper and a lower trough-shaped recess 11c, 11d are formed. Trough-shaped recesses 11c and 11d of second membrane 11 have a smaller depth than trough-shaped recess 10d of first membrane 10.
The two membranes 10, 11 are held in a clamped manner by means of a retaining plate 13, which is inserted in a snap-in or lock-in manner into side part 3 of the cap. The edge of retaining plate 13 sits in an annular groove 14, which runs at the inside of side part 3 beneath lid part 2.
In the region of openings 8, 9, lid part 2 of cap 1 has a shape complementary to membranes 10, 11, so that the membranes sit in a matching fashion in the lid part. The membranes are supported with the upper seating faces at the underside of lid part 2.
Retaining plate 13 has two openings 8a and 9a, which have the same or a larger diameter than corresponding openings 8 and 9 of lid part 2. Openings 8a and 9a are surrounded by annular shoulders 15, 16, which lie adjacent to the lower seating faces of membranes 10, 11.
For the assembly, membranes 10, 11 are inserted into openings 8, 9 of lid part 2 of cap 1. Retaining plate 13 is then inserted into cap 1, so that membranes 10, 11 are clamped between the lid part and the retaining plate.
Removal site 6 and injection site 7 of the cap are each obturated with a twist-off part 17, 18, which forms an originality seal. Both twist-off parts 17, 18 are configured as flat grip parts, which are each connected via a circular rupture zone 19, 20 to lid part 2. These grip parts can easily be twisted off by hand. Grip part 17 has a recess 21 configured in the manner of an arrow which points upwards, whilst grip part 18 has a recess 22 configured in the manner of an arrow which points downwards. As a result, it becomes clear that removal site 6 is exposed after twisting off grip part 17 and the injection site after twisting off grip part 18.
For the removal of a medical liquid, grip part 17 of removal site 6 is twisted off and a piercing part (not shown), for example a spike of a transfusion device for enteral nutritive solutions or an infusion device, is introduced into opening 8 of lid part 2. Pre-slit membrane 10 is thereby pierced, so that access to the container is produced.
For the injection of an additive, grip part 18 is snapped off and the cannula of a syringe is pierced into membrane 11 of injection site 7.
Lid part 2′ of cap 1′ from
For the assembly of the cap, the two membranes 10, 11 are inserted into folded-down lid part 2′, and lid part 2′ is folded onto retaining plate 13′, lug 31a being snapped into groove 31b. The membranes are again clamped between the retaining part and the lid part.
a and 3b show a further example of embodiment of the closing cap, which differs from the embodiments described by reference to
Shoulders 15′, 16′ for clamping membranes 10, 11 are annular sleeves at the underside of lid part 2, the diameter of which sleeves corresponds to the diameter of openings 8, 9. Sleeve-shaped shoulder 15′ of removal site 6 has a greater length than shoulder 16′ of injection site 7.
Membranes 10, 11 are first inserted into openings 8, 9 (
Number | Date | Country | Kind |
---|---|---|---|
10 2004 051 300 | Oct 2004 | DE | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP2005/008787 | 8/12/2005 | WO | 00 | 7/17/2008 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2006/042579 | 4/27/2006 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2804224 | Barton | Aug 1957 | A |
3758000 | Mack | Sep 1973 | A |
3900028 | McPhee | Aug 1975 | A |
3904060 | McPhee | Sep 1975 | A |
3905368 | Lewis et al. | Sep 1975 | A |
3938519 | McPhee | Feb 1976 | A |
4153173 | Ward et al. | May 1979 | A |
4187149 | Tolbert et al. | Feb 1980 | A |
4227954 | Ward et al. | Oct 1980 | A |
RE31082 | Winchell | Nov 1982 | E |
4412573 | Zdeb | Nov 1983 | A |
4501372 | Hansen | Feb 1985 | A |
4516977 | Herbert | May 1985 | A |
4547900 | Larkin et al. | Oct 1985 | A |
4892222 | Schmidt et al. | Jan 1990 | A |
5025955 | Stenger | Jun 1991 | A |
5088995 | Packard et al. | Feb 1992 | A |
5171234 | Jepson et al. | Dec 1992 | A |
5259843 | Watanabe et al. | Nov 1993 | A |
3136440 | Krug et al. | Jun 1994 | A |
5320232 | Maguire et al. | Jun 1994 | A |
5356018 | Dubach | Oct 1994 | A |
5678713 | Derksen | Oct 1997 | A |
5896989 | Ropiak et al. | Apr 1999 | A |
6039718 | Niedospial, Jr. | Mar 2000 | A |
6375028 | Smith | Apr 2002 | B1 |
6868978 | Amschlinger et al. | Mar 2005 | B2 |
6893428 | Willemstyn | May 2005 | B2 |
6904662 | Thibault et al. | Jun 2005 | B2 |
7137519 | Becker | Nov 2006 | B2 |
7334310 | Becker | Feb 2008 | B2 |
7780636 | Radmer et al. | Aug 2010 | B2 |
7828787 | Brandenburger et al. | Nov 2010 | B2 |
20020066715 | Niedospial, Jr. | Jun 2002 | A1 |
20030075469 | Herbert | Apr 2003 | A1 |
20030233083 | Houwaert et al. | Dec 2003 | A1 |
20040112855 | Becker | Jun 2004 | A1 |
20050215943 | Brandenburger et al. | Sep 2005 | A1 |
20060138070 | Domkowski et al. | Jun 2006 | A1 |
20090054865 | Brandenburger et al. | Feb 2009 | A1 |
Number | Date | Country |
---|---|---|
1098084 | Mar 1981 | CA |
2393572 | Jun 2001 | CA |
2584384 | Apr 2006 | CA |
1498600 | Mar 1970 | DE |
2 501 821 | Jan 1975 | DE |
2501821 | Aug 1975 | DE |
2 909 859 | Mar 1979 | DE |
2909859 | Sep 1979 | DE |
83 08 416 | Mar 1983 | DE |
8308416 | Jun 1983 | DE |
3543825 | Jun 1986 | DE |
19728775 | Jan 1999 | DE |
199 58 952 | Aug 1999 | DE |
69416696 | Sep 1999 | DE |
102 23 560 | Jan 2001 | DE |
19958952 | Jun 2001 | DE |
10030474 | Feb 2002 | DE |
10223560 | Dec 2003 | DE |
102004051300 | Nov 2005 | DE |
0 364 783 | Sep 1989 | EP |
0 495 330 | Jul 1992 | EP |
0 766 955 | Aug 1996 | EP |
737058 | Oct 1996 | EP |
0766955 | Apr 1997 | EP |
1 010 635 | Jun 2000 | EP |
1 010 635 | Mar 2003 | EP |
1010635 | Mar 2004 | EP |
1 469 043 | Mar 1977 | GB |
1469043 | Mar 1977 | GB |
2 121 016 | Dec 1983 | GB |
54-129795 | Oct 1979 | JP |
55-101 758 | Apr 1980 | JP |
55-101758 | Jul 1980 | JP |
05-022136 | Jan 1993 | JP |
05-038694 | Feb 1993 | JP |
6-75496 | Oct 1994 | JP |
7-27578 | May 1995 | JP |
08-322909 | Oct 1996 | JP |
2004-129867 | Apr 2004 | JP |
2004-527408 | Sep 2004 | JP |
9517873 | Jul 1995 | WO |
9623545 | Aug 1996 | WO |
WO0160699 | Aug 2001 | WO |
WO 02098748 | Dec 2002 | WO |
WO02098748 | Dec 2002 | WO |
03099191 | Dec 2003 | WO |
2005035032 | Apr 2005 | WO |
2006042579 | Apr 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20090054865 A1 | Feb 2009 | US |